Login / Signup

Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma.

Maria Chiara TisiRossella PaoliniFrancesco PiazzaErika RavelliCristina TecchioRoberto SartoriBarbara FamengoEmanuele Stefano Giovanni D'AmoreGiuseppe CarliOmar PerbelliniEros Di BonaMarco RuggeriCarlo Visco
Published in: American journal of hematology (2018)
Keyphrases
  • diffuse large b cell lymphoma
  • acute myeloid leukemia
  • high dose
  • chronic lymphocytic leukemia
  • hodgkin lymphoma
  • acute lymphoblastic leukemia
  • low dose
  • multiple myeloma